Clinic Software
Phinomics
From Invisible Biology to Tomorrow’s Therapeutics
About
Phinomics is unlocking a hidden layer of biology—circular DNA and cryptic proteins—to power the next generation of AI in precision medicine. While others models train on a static, 1-D linear genome, we see a 3D, dynamic ecosystem of disease-driving elements. Our platform decodes and quantifies these overlooked signals and integrates them into high-resolution, multimodal maps of disease biology—connecting circular DNA with expression, epigenetics, and clinical outcomes. But the real breakthrough isn’t just better data—it’s what we do with it. Phinomics trains AI on orthogonal, causal, and clinically validated signals that go far beyond conventional inputs. The result is biological intelligence that understands disease from the inside out, powering new models for prediction, precision, and cure. That’s Phinomics. The lens into biology no one else has and the data engine that will power the future of precision medicine.
Product
- Value proposition
- Phinomics provides a first-in-class Circulome data layer and multi-omic integration to reveal causal mechanisms in cancer biology, enabling targeted therapeutic discovery and patient stratification.
- Target customers
- pharma/biotech companies, research institutions, CROs
Founders
- Stephen Levene — Co-Founder
- Massa Shoura — Co-Founder
Categories
Products
Key features
Technologies
Target conditions
Competitors
Investors
News
- Phinomics - 2026 Company Profile, Team, Funding & Competitors · 2026-05-21T00:00:00.000Z
- Beyond the Double Helix: Phinomics Joins "All Access hosted by Andy Garcia" to Explore Hidden Frontiers in Genetics · 2026-06-12T07:00:00.000Z
- New insights into eccDNA could revolutionise cancer understanding and explainable AI in genomics | Noah News · 2026-06-12T07:59:18.000Z
- Guido Mathews' Post - LinkedIn · 2026-06-09T00:00:00.000Z
- PMWC 2026 | Precision Medicine World Conference, March 4–6 · 2026-01-28T00:00:00.000Z
